作者:
Thomas J,Covey [1]
;
Daniel,Golan [2]
;
Robert,Sergott [3]
;
Jeffrey,Wilken [4]
;
Myassar,Zarif [5]
;
Barbara,Bumstead [6]
;
MariJean,Buhse [7]
;
Olivia,Kaczmarek [7]
;
Glen M,Doniger [7]
;
Iris-Katharina,Penner [7]
;
Laura M,Hancock [8]
;
Hans,Bogaardt [9]
;
Marissa A,Barrera [10]
;
Sarah A,Morrow [11]
;
Steve,Galetta [12]
;
Mark,Gudesblatt [13]
作者单位:
Division of Cognitive and Behavioral Neurosciences, Department of Neurology, Neuroscience Program, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Sherman Hall Annex 114, Buffalo, NY, USA. tjcovey@buffalo.edu.
[1]
Multiple Sclerosis and Neuroimmunology Center, Clalit Health Services, Nazareth, Israel.
[2]
Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
[3]
Wills Eye Institute and the William H. Annesley EyeBrain Center, Thomas Jefferson University, Philadelphia, PA, USA.
[4]
Washington Neuropsychology Research Group, Fairfax, VA, USA.
[5]
Department of Neurology, Georgetown University, Washington, DC, USA.
[6]
South Shore Neurologic Associates, New York University, Patchogue, New York, NY, USA.
[7]
Department of Clinical Research, NeuroTrax Corporation, Modiin, Israel.
[8]
Department of Neurology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
[9]
Department of Neurology, University of Wisconsin School of Medicine, Madison, WI, USA.
[10]
School of Allied Health Science and Practice, University of Adelaide, Adelaide, Australia.
[11]
Katz School of Science and Health, Yeshiva University, New York, NY, USA.
[12]
London Health Sciences Centre, University of Western Ontario, Ontario, ON, Canada.
[13]
Department of Neurology, New York University, New York, NY, USA.
[14]
South Shore Neurologic Associates, New York University, Patchogue, New York, NY, USA. mark.gudesblatt@nyulangone.org.
[15]
DOI
10.1007/s00415-023-12075-5
PMID
38091086
发布时间
2024-03-23